PortfoliosLab logoPortfoliosLab logo
THQ vs. FBIOX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

THQ vs. FBIOX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Abrdn Healthcare Opportunities Fund (THQ) and Fidelity Select Biotechnology Portfolio (FBIOX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, THQ achieves a 3.92% return, which is significantly lower than FBIOX's 21.02% return. Over the past 10 years, THQ has underperformed FBIOX with an annualized return of 9.78%, while FBIOX has yielded a comparatively higher 11.63% annualized return.


THQ

1D
-1.21%
1M
1.67%
6M
0.45%
YTD
3.92%
1Y
17.81%
3Y*
10.58%
5Y*
4.34%
10Y*
9.78%

FBIOX

1D
-2.44%
1M
14.97%
6M
22.43%
YTD
21.02%
1Y
64.77%
3Y*
23.93%
5Y*
8.10%
10Y*
11.63%
*Multi-year figures are annualized to reflect compound growth (CAGR)

THQ vs. FBIOX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
THQ
Abrdn Healthcare Opportunities Fund
3.92%13.88%15.51%-1.62%-17.53%33.39%15.20%22.70%3.41%21.84%
FBIOX
Fidelity Select Biotechnology Portfolio
21.02%36.38%7.26%10.09%-15.87%-12.26%38.62%36.12%-10.92%27.87%

Correlation

The correlation between THQ and FBIOX is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.52

Correlation (3Y)
Calculated over the trailing 3-year period

0.55

Correlation (5Y)
Calculated over the trailing 5-year period

0.57

Correlation (10Y)
Calculated over the trailing 10-year period

0.59

Correlation (All Time)
Calculated using the full available price history since Jul 29, 2014

0.59

The correlation between THQ and FBIOX has been stable across timeframes, ranging from 0.52 to 0.59 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

THQ vs. FBIOX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

THQ
THQ Risk / Return Rank: 1919
Overall Rank
THQ Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
THQ Sortino Ratio Rank: 2121
Sortino Ratio Rank
THQ Omega Ratio Rank: 2020
Omega Ratio Rank
THQ Calmar Ratio Rank: 1717
Calmar Ratio Rank
THQ Martin Ratio Rank: 1717
Martin Ratio Rank

FBIOX
FBIOX Risk / Return Rank: 9494
Overall Rank
FBIOX Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
FBIOX Sortino Ratio Rank: 9191
Sortino Ratio Rank
FBIOX Omega Ratio Rank: 8585
Omega Ratio Rank
FBIOX Calmar Ratio Rank: 9898
Calmar Ratio Rank
FBIOX Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

THQ vs. FBIOX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Abrdn Healthcare Opportunities Fund (THQ) and Fidelity Select Biotechnology Portfolio (FBIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


THQFBIOXDifference
Sharpe ratioReturn per unit of total volatility

-1.95

Sortino ratioReturn per unit of downside risk

-2.39

Omega ratioGain probability vs. loss probability

1.18

1.46

-0.28

Calmar ratioReturn relative to maximum drawdown

1.07

8.21

-7.14

Martin ratioReturn relative to average drawdown

3.22

25.01

-21.79

THQ vs. FBIOX - Sharpe Ratio Comparison

The current THQ Sharpe Ratio is 0.95, which is lower than the FBIOX Sharpe Ratio of 2.91. The chart below compares the historical Sharpe Ratios of THQ and FBIOX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

THQ vs. FBIOX - Drawdown Comparison

The maximum THQ drawdown since its inception was -39.35%, smaller than the maximum FBIOX drawdown of -71.98%. Use the drawdown chart below to compare losses from any high point for THQ and FBIOX.


Loading charts...

Drawdown Indicators


THQFBIOXDifference

Max Drawdown

Largest peak-to-trough decline

-39.35%

-71.98%

+32.63%

Max Drawdown (1Y)

Largest decline over 1 year

-16.74%

-7.62%

-9.12%

Max Drawdown (3Y)

Largest decline over 3 years

-25.86%

-27.83%

+1.97%

Max Drawdown (5Y)

Largest decline over 5 years

-32.20%

-44.87%

+12.67%

Max Drawdown (10Y)

Largest decline over 10 years

-39.35%

-48.66%

+9.31%

Current Drawdown

Current decline from peak

-1.99%

-2.44%

+0.45%

Average Drawdown

Average peak-to-trough decline

-8.58%

-23.57%

+14.99%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.55%

2.50%

+3.05%

Volatility

THQ vs. FBIOX - Volatility Comparison

The current volatility for Abrdn Healthcare Opportunities Fund (THQ) is 6.26%, while Fidelity Select Biotechnology Portfolio (FBIOX) has a volatility of 6.90%. This indicates that THQ experiences smaller price fluctuations and is considered to be less risky than FBIOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


THQFBIOXDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.26%

6.90%

-0.64%

Volatility (6M)

Calculated over the trailing 6-month period

13.94%

17.10%

-3.16%

Volatility (1Y)

Calculated over the trailing 1-year period

18.80%

21.55%

-2.75%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.21%

25.11%

-5.90%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

20.52%

26.16%

-5.64%

THQ vs. FBIOX - Expense Ratio Comparison

THQ has a 1.47% expense ratio, which is higher than FBIOX's 0.69% expense ratio.


Dividends

THQ vs. FBIOX - Dividend Comparison

THQ's dividend yield for the trailing twelve months is around 11.51%, more than FBIOX's 5.56% yield.


PositionTTM20252024202320222021202020192018201720162015
FBIOX
Fidelity Select Biotechnology Portfolio
5.56%2.47%1.21%0.45%0.00%14.48%19.46%8.89%11.18%1.41%3.42%6.71%
THQ
Abrdn Healthcare Opportunities Fund
11.51%11.29%11.09%7.45%6.81%5.27%6.62%7.08%8.05%7.71%8.70%9.50%

Frequently Asked Questions


THQ and FBIOX have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FBIOX has higher volatility (6.90%) compared to THQ (6.26%). In terms of maximum drawdown, THQ dropped -39.35% vs FBIOX's -71.98%.

FBIOX currently has the higher Sharpe Ratio (2.91 vs 0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for THQ and FBIOX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer